A coronary stent made of a chromium alloy (cobalt or platinum) with a continuous sinusoidal configuration and a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR | A coronary stent made of a chromium alloy (cobalt or platinum) with a bioabsorbable polymer and hybrid coating with an active component of an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR and a passive component that lowers the thrombogenicity | A coronary stent made of a chromium and cobalt alloy with an abluminal biodegradable polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR. Diameter 2.0-4.5mm, length 9-50mm. | A coronary stent made of a chromium and cobalt alloy with a hybrid cell design and a low stent crossing profile ≤ 0.041” (it refers to a stent with a diameter of up to 3mm), with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR | A coronary stent made of multiple cobalt alloys (chromium or nickel) designed for large post-dilatation expansions ≥ 5.5mm in large blood vessels, with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR | A coronary stent made of a chromium and platinum alloy with a permanent polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR | A coronary stent made of a chromium and platinum alloy with an abluminal biodegradable polymer, coated with an immunosuppressant that stops the cell cycle progression by inhibiting the m-TOR, with a diameter from 2.25 to 5mm, length from 8 to 48mm, compatible with 5F guiding catheter for all dimensions | A coronary stent made of a chromium and cobalt alloy, with a polymer and carrier free technology, coated with an immunosuppressant on the abluminal surface that stops the cell cycle progression by inhibiting the...
This is one of 22 active North Macedonia Health Services opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | Public Health Institution Specialized Hospital for Prevention, Treatment and Rehabilitation of Cardiovascular Diseases – Ohrid |
|---|
| Country | North Macedonia |
|---|
| Category | Health Services |
|---|
| Estimated value | $518,048 |
|---|
| Published | September 02, 2026 |
|---|
| Procurement stage | Request for Proposal (RFP) |
|---|
| Response due | September 30, 2026 |
|---|
| Status | Open — accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | September 27, 2026 |
|---|
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
See every North Macedonia Health Services opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free North Macedonia Health Services intelligence report in your inbox
A personalized report on North Macedonia Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.